Successful MDR-TB treatment regimens including Amikacin are associated with high rates of hearing loss

BACKGROUND: Aminoglycosides are a critical component of multidrug-resistant tuberculosis (MDR-TB) treatment but data on their efficacy and adverse effects in Botswana is scarce. We determined the effect of amikacin on treatment outcomes and development of hearing loss in MDR-TB patients. METHODS: Pa...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:BMC Infect Dis
Prif Awduron: Modongo, Chawangwa, Sobota, Rafal S, Kesenogile, Boikobo, Ncube, Ronald, Sirugo, Giorgio, Williams, Scott M, Zetola, Nicola M
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BioMed Central 2014
Pynciau:
Research Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4287509/
https://ncbi.nlm.nih.gov/pubmed/25300708
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2334-14-542
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg